NEW YORK (GenomeWeb News) – Molecular diagnostics developer Rules-Based Medicine said today that it will collaborate with the Institut Pasteur on a project aimed at gaining a better understanding of the human immune system.
RBM will use its TruCulture in vitro model in the project called Milieu Interieur to "establish the parameters that characterize the immune system of healthy individuals," RBM said.
The company's TruCulture system, which will be used for blood collection and culture, captures immune cell activity without many of the variables associated with sample collection and manipulation, RBM said. An important advantage of TruCulture, it added, is that cell stimulations are performed at the point of collection, providing a more accurate picture of a subject's immune response and allowing researchers to describe individual differences at the genomic, proteomic, and inflammation pathway levels.
Milieu Interieur is funded through a LabEx grant from the French government. As part of it, researchers from Institut Pasteur, the French National Institute of Health and Medical Research, and the National Centre for Scientific Research will employ technology from disciplines such as genomics, molecular biology, bioinformatics, and immunology, with the hopes that therapeutic strategies may be tailored for specific individuals, RBM said.
Terms of the deal were not disclosed.
Myriad Genetics is in the process of buying Austin, Texas-RBM for $80 million.